OSX · ASX

Osteopore Ltd. (ASX:OSX)

AU$0.034

 -0.0015 (-4.167%)
ASX:Live
24/12/2024 01:34:27 PM
Near Support Near 52 Week Low HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

OSX Overview

OSX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

OSX Price Chart

Key Stats

Market Cap

AU$4.51M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

-6.76%

1 month

-11.54%

YTD

-72.03%

1 year

-74.27%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

OSX Announcements

Latest Announcements

Date Announcements

24 December 24

OSX enters agreement to issue redeemable convertible notes

×

OSX enters agreement to issue redeemable convertible notes

23 December 24

Results of General Meeting

×

Results of General Meeting

21 November 24

Notice of General Meeting

×

Notice of General Meeting

19 November 24

Application for quotation of securities - OSX

×

Application for quotation of securities - OSX

15 November 24

Application for quotation of securities - OSX

×

Application for quotation of securities - OSX

06 November 24

Osteopore inks DKSH deal to sell ortho products in Singapore

×

Osteopore inks DKSH deal to sell ortho products in Singapore

04 November 24

OSX partners scientists to drive regeneration innovation

×

OSX partners scientists to drive regeneration innovation

01 November 24

Application for quotation of securities - OSX

×

Application for quotation of securities - OSX

31 October 24

Activities Report September 2024 and Appendix 4C

×

Activities Report September 2024 and Appendix 4C

24 October 24

Osteopore Secures Brazilian Craniofacial Distribution Deal

×

Osteopore Secures Brazilian Craniofacial Distribution Deal

17 October 24

Osteopore strikes collaboration with NASDAQ-listed CytoMed

×

Osteopore strikes collaboration with NASDAQ-listed CytoMed

10 October 24

Osteopore strikes scaffold-based iPSC deal with RxCell

×

Osteopore strikes scaffold-based iPSC deal with RxCell

10 October 24

Osteopore Ltd. - Osteopore strikes scaffold-based iPSC deal with RxCell (OSX-AU)

×

Osteopore Ltd. - Osteopore strikes scaffold-based iPSC deal with RxCell (OSX-AU)

10 October 24

Osteopore Ltd. - Osteopore strikes scaffold-based iPSC deal with RxCell (OSX-AU)

×

Osteopore Ltd. - Osteopore strikes scaffold-based iPSC deal with RxCell (OSX-AU)

10 October 24

Osteopore Ltd. - Osteopore strikes scaffold-based iPSC deal with RxCell (OSX-AU)

×

Osteopore Ltd. - Osteopore strikes scaffold-based iPSC deal with RxCell (OSX-AU)

27 September 24

Osteopore to raise A$20m via redeemable convertible note

×

Osteopore to raise A$20m via redeemable convertible note

26 September 24

Revised Initial Director's Interest Notice - Yujing Lim

×

Revised Initial Director's Interest Notice - Yujing Lim

25 September 24

Initial Director's Interest Notice - Yujing Lim

×

Initial Director's Interest Notice - Yujing Lim

24 September 24

Appointment of Executive Director - Dr Yujing Lim

×

Appointment of Executive Director - Dr Yujing Lim

30 August 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

22 August 24

OSX and University of Chile complete bone implant studies

×

OSX and University of Chile complete bone implant studies

31 July 24

Activities Update Qtr Ending June 2024 and Appendix 4C

×

Activities Update Qtr Ending June 2024 and Appendix 4C

31 July 24

Application for quotation of securities - OSX

×

Application for quotation of securities - OSX

26 July 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

OSX Fundamentals

Per Share Records

Historical data

Forecast data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.08 -0.09 -0.09 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.08 -0.09 -0.09 Lock Lock Lock
     Growth % Lock Lock Lock Lock -69.2 -9.9 -1.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.07 -0.09 -0.07 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.09 -0.09 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -97.5 -13.9 22.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -15.2 -21.9 -59.4 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.12 0.04 0.01 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.12 0.04 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -40.3 -63.8 -113.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 44 47 53 Lock Lock Lock
Basic m Lock Lock Lock Lock 44 47 53 Lock Lock Lock

Financial Records

Historical data

Forecast data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales AU$m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -26.0 52.1 31.0 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 4 5 6 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -25.7 79.9 -39.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 52.7 62.3 28.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 47 38 71 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -4 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.0 -9.2 -11.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -329.6 -236.6 -200.7 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -4 -4 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.2 -8.4 -16.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -349.8 -249.5 -221.6 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -4 -4 -5 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -4 -4 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -86.1 -15.9 -16.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -325.3 -247.9 -219.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -4 -4 -4 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 0 1 4 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -4 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -87.0 -1.4 7.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3.6 -2.4 -1.7 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 5 1 1 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 6 4 3 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -4 -1 0 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 1 2 3 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 5 2 0 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 5 2 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -39.5 -61.8 -79.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -60.3 -116.5 -145.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -67.4 -204.5 -1,126.2 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -52.2 -111.0 -276.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -50.2 -111.5 -387.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -52.7 -106.2 -297.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -225.0 -401.7 -295.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.2 0.3 0.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -82.3 -61.4 -28.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 9.6 2.1 0.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 9.2 1.9 0.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 83.6 42.6 48.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -674.2 -262.6 -128.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.9 2.6 2.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 3.0 2.7 5.7 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 1.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 25.1 54.3 35.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.5 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.5 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -325.3 -247.9 -217.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -60.3 -116.5 -144.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -60.3 -116.5 -145.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.8 7.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -67.4 -204.5 -1,126.2 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -67.4 -204.5 -1,126.2 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 122.3 137.5 64.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 125.0 140.5 124.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 247.3 278.0 188.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 191.3 342.7 196.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 55.9 -64.6 -7.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OSX Shortsell

Frequently Asked Questions

The current share price of Osteopore Ltd. (OSX:ASX) is AU$0.034.
The 52-week high share price for Osteopore Ltd. (OSX:ASX) is AU$0.00.
The 52-week low share price for Osteopore Ltd. (OSX:ASX)? is AU$0.00.
Osteopore Ltd. (OSX:ASX) does not pay a dividend.
Osteopore Ltd. (OSX:ASX) does not pay a dividend.
Osteopore Ltd. (OSX:ASX) does not offer franking credits.
Osteopore Ltd. (OSX:ASX) is classified in the Healthcare.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.